{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
STRATA Skin Sciences, Inc.
STRATA Skin Sciences Hits New 52-Week Low at $1.30
STRATA Skin Sciences, Inc. has reached a new 52-week low, reflecting a significant decline in its stock value over the past year. The company, with a market capitalization of approximately USD 9 million, faces challenges including high debt levels, negative returns, and operating losses, complicating its financial outlook.
STRATA Skin Sciences Hits 52-Week Low of $1.33 Amid Financial Struggles
STRATA Skin Sciences, Inc. has reached a new 52-week low, reflecting a significant decline in performance over the past year. The company, with a market capitalization of approximately USD 9 million, faces substantial operating losses, high leverage, and weak long-term growth, indicating a challenging financial environment.
STRATA Skin Sciences Hits 52-Week Low of $1.83 Amidst Declining Stock Performance
STRATA Skin Sciences, Inc. has reached a 52-week low of $1.83, reflecting a 52.7% decline over the past year. With a market capitalization of around $9 million, the company faces financial challenges, including a high debt-to-equity ratio and negative return on equity, while lacking a dividend yield.
Is STRATA Skin Sciences, Inc. overvalued or undervalued?
As of October 3, 2023, STRATA Skin Sciences, Inc. is considered an attractive investment due to its undervalued financial metrics, including a price-to-earnings ratio of 15.2, compared to higher ratios of its peers, and strong recent stock performance.
Is STRATA Skin Sciences, Inc. technically bullish or bearish?
As of November 1, 2023, there is not enough technical data to assess the current stance of STRATA Skin Sciences, Inc.
Who are in the management team of STRATA Skin Sciences, Inc.?
As of March 2022, the management team of STRATA Skin Sciences, Inc. includes Dr. Uri Geiger (Chairman), Dr. Dolev Rafaeli (President and Interim CEO), and six independent directors: Mr. Samuel Navarro, Mr. Samuel Rubinstein, Mr. Nachum Shamir, Mr. David Stone, and Ms. LuAnn Via.
What does STRATA Skin Sciences, Inc. do?
STRATA Skin Sciences, Inc. is a medical technology company focused on developing and commercializing products for dermatological disorders. As of March 2025, it reported net sales of $7 million and a net loss of $2 million, with a market cap of $9.51 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
